This guide is designed as a practical tool for the Oncologists, aimed at facilitating the decision making on the antiemetic therapy to be administered to patients undergoing a specific chemotherapy (CT) regimen. While it offers information on CT regimens’ schedules and emetogenicity, this guide is not a tool for CT choice. Please consult guidelines and package inserts for exact dosages, notes and warnings on CT agents and combinations.
Information included herein is based on data from the latest ASCO, ESMO, MASCC, NCCN, and NCI guidelines, and it has been integrated with relevant evidences from the international scientific literature.
This guide is a summary of cancer therapeutic agents and regimens and of their emetogenicity according to the available evidences and guidelines. Although detailed, this guide is not intended or designed as an exhaustive review. No liability will be assumed by Helsinn Healthcare SA for the use of this tool and the absence of errors, omissions, or inaccuracies is not guaranteed. For detailed information on single agents, regimens, dosages, and indications, the user is invited to consult drugs’ prescribing information as well as international literature and guidelines.
This application is intended for non-US physicians only.

Copyright © 2014 Helsinn Healthcare SA